Clinical trialNCT00099320CompletedPhase 3Interventional

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

SponsorAstraZenecaEnrollment182Type 2 Diabetes Mellitus

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

James Malone, MD
Eli Lilly and Company
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

51 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

Research Site
Calgary, Alberta, Canada
Research Site
Vancouver, British Columbia, Canada
Research Site
Dartmouth, Nova Scotia, Canada
Research Site
London, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Montreal, Quebec, Canada

Spain

Research Site
Granada, Spain
Research Site
Seville, Spain
Research Site
Valencia, Spain
Research Site
Valladolid, Spain
Research Site
Zaragoza, Spain

United States

Research Site
Birmingham, Alabama, United States
Research Site
La Jolla, California, United States
Research Site
San Mateo, California, United States
Research Site
Santa Barbara, California, United States
Research Site
Spring Valley, California, United States
Research Site
Hialeah, Florida, United States
Research Site
Jacksonville, Florida, United States
Research Site
Melbourne, Florida, United States
Research Site
West Palm Beach, Florida, United States
Research Site
Atlanta, Georgia, United States
Research Site
Honolulu, Hawaii, United States
Research Site
Idaho Falls, Idaho, United States
Research Site
Chicago, Illinois, United States
Research Site
Baton Rouge, Louisiana, United States
Research Site
Kalamazoo, Michigan, United States
Research Site
Troy, Michigan, United States
Research Site
Butte, Montana, United States
Research Site
McCook, Nebraska, United States
Research Site
North Platte, Nebraska, United States
Research Site
Omaha, Nebraska, United States
Research Site
Scottsbluff, Nebraska, United States
Research Site
Princeton, New Jersey, United States
Research Site
Albuquerque, New Mexico, United States
Research Site
Albany, New York, United States
Research Site
New York, New York, United States
Research Site
Rochester, New York, United States
Research Site
Greenville, North Carolina, United States
Research Site
Cleveland, Ohio, United States
Research Site
Greenville, South Carolina, United States

11 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 May 2004
Primary completion: 31 Aug 2005
Completion: 31 Aug 2005
Last update posted: 23 Feb 2015
Registered enrollment: 182
Registry id: NCT00099320

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.